For patients with Stage III or IV colon and rectal cancer, especially those who are non-responsive to conventional therapies, immunotherapy offers new hope for long-term survival.

In comparison to American adults born in 1950, those born in 1990 have twice the risk of developing colon cancer and four times the risk of developing rectal cancer, the researchers found.

Understanding the risk factors of colorectal cancer can help you reduce the chances of developing it. Find out what steps you can take.

AI assistance is associated with a superior improvement in detecting clinically significant prostate cancer on MRI, a diagnostic study finds.

Colorectal cancer is the second-leading cause of cancer related death in the U.S., with nearly 53,0001 fatalities expected in 2025. While the burden of this disease is significant, advancements in ...

Even though rectal bleeding is alarming, doctors say patients are ashamed to mention it, delaying colon cancer diagnosis and treatment.

Terence M. Williams, MD, PhD, a professor and chair in the Department of Radiation Oncology at City of Hope, discusses what inspired the new phase 1 DINOMITE trial (NCT06834126) at City of Hope that ...

Absence of progression correctly identified by subsequent MRI in nearly 95, 90, 70 percent of men with grade group 0, 1, 2, respectively.

A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery and other types of more invasive treatment to cure their disease.

A New Paradigm in Rectal Cancer Treatment Together, these five studies demonstrate the transformative potential of radiotherapy as a curative and organ-preserving treatment.

New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy, surgery, and radiation for some forms of cancer.